Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty

YKL-05-099

YKL-05-099
YKL-05-099 is an inhibitor of the salt-inducible kinase(SIK1 and SIK3 ; IC50s: 10 and 30 nM, respectively). It has a slightly less potent SIK2-inhibitory (IC50:40 nM).
Catalog No. T17271Cas No. 1936529-65-5
Select Batch
Purity:99.66%
Contact us for more batch information
Resource Download

YKL-05-099

Catalog No. T17271Cas No. 1936529-65-5
YKL-05-099 is an inhibitor of the salt-inducible kinase(SIK1 and SIK3 ; IC50s: 10 and 30 nM, respectively). It has a slightly less potent SIK2-inhibitory (IC50:40 nM).
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Pack SizePriceAvailabilityQuantity
1 mg$68In Stock
5 mg$123In Stock
10 mg$189In Stock
25 mg$328In Stock
50 mg$488In Stock
100 mg$689In Stock
1 mL x 10 mM (in DMSO)$162In Stock
Bulk & Custom
Add to Cart
Questions
View More

Related Compound Libraries of "YKL-05-099"

Product Introduction

Bioactivity
Description
YKL-05-099 is an inhibitor of the salt-inducible kinase(SIK1 and SIK3 ; IC50s: 10 and 30 nM, respectively). It has a slightly less potent SIK2-inhibitory (IC50:40 nM).
Targets&IC50
SIK1:10 nM, SIK2:40 nM, SIK3:30 nM
In vitro
YKL-05-099 inhibits the production of the inflammatory cytokines TNFα, IL-6 and IL-12p40, and only modestly enhances IL-1β release in BMDCs stimulated with the yeast cell wall extract Zymosan A. YKL-05-099 has slightly less potent SIK2-inhibitory (IC50=40 nM) and IL-10-enhancing activities (EC50=460 nM). YKL-05-099 binds to SIK1 and SIK3 (IC50s: 10 and 30 nM, respectively, in a competitive binding assay). Preincubating bone marrow-derived macrophages with YKL-05-099 decreases LPS stimulated phosphorylation of HDAC5 at the SIK-specific phosphorylation site Ser259 [1].
In vivo
YKL-05-099 exhibits high solubility (PBS solubility=428 μM) and is predominantly in an unbound state in mouse plasma, displaying non-toxic characteristics at concentrations below 10 μM. This compound is metabolically stable, showing more than 2 hours of stability in mouse liver microsomes. Functionally, YKL-05-099 effectively modulates immune response by reducing TNFα levels in a dose-dependent manner, starting at 5 mg/Kg, and significantly enhancing IL-10 secretion at a 20 mg/Kg dose, achieving a more than two-fold increase. Furthermore, it inhibits phosphorylation of HDAC5 at the SIK-regulated site (Ser259) in a dose-responsive manner, with notable reduction starting at 5 mg/Kg and becoming undetectable by immunoblotting from the 20 mg/Kg dose onwards [1].
Chemical Properties
Molecular Weight600.11
FormulaC32H34ClN7O3
Cas No.1936529-65-5
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice.
Solubility Information
DMSO: 45 mg/mL (74.99 mM)
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM1.6664 mL8.3318 mL16.6636 mL83.3181 mL
5 mM0.3333 mL1.6664 mL3.3327 mL16.6636 mL
10 mM0.1666 mL0.8332 mL1.6664 mL8.3318 mL
20 mM0.0833 mL0.4166 mL0.8332 mL4.1659 mL
50 mM0.0333 mL0.1666 mL0.3333 mL1.6664 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the mother liquor preparation method and in vivo formula preparation method:
TargetMol | Animal experimentsFor example, your dosage is 10 mg/kg Each animal weighs 20 g, and the dosage volume is 100 μL . TargetMol | Animal experiments A total of 10 animals were administered, and the formula you used is 5% TargetMol | reagent DMSO+30% PEG300+5% Tween 80+60% ddH2O. So your working solution concentration is 2 mg/mL。
Mother liquor preparation method: 2 mg of drug dissolved in 50 μL DMSOTargetMol | reagent (mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first.
Preparation method for in vivo formula: Take 50 μL DMSOTargetMol | reagent main solution, add 300 μLPEG300TargetMol | reagent mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLddH2OTargetMol | reagent mix well and clarify
For Reference Only. Please develop an appropriate dissolution method based on your laboratory animals and route of administration.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
%Tween 80
%ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy YKL-05-099 | purchase YKL-05-099 | YKL-05-099 cost | order YKL-05-099 | YKL-05-099 chemical structure | YKL-05-099 in vivo | YKL-05-099 in vitro | YKL-05-099 formula | YKL-05-099 molecular weight